로딩 중…
지수 로딩 중…
Zevra Therapeutics, Inc.
ZVRA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$12.90+2.30%
2026-06-18
Price Chart
Zevra Therapeutics, Inc.+42.23%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $763M |
| Revenue | $122M |
| Net Income | $124M |
| Total Assets | $279M |
| Net Assets | $206M |
| Value | |
| P/E | 6.14x |
| P/B | 3.71x |
| P/S | 6.24x |
| EV/EBITDA | 6.29x |
| FCF Yield | 1.57% |
| Profitability | |
| ROE | 60.36% |
| ROA | 44.59% |
| Op. Margin | -39.86% |
| Revenue Growth | 77.54% |
| Financial Health | |
| Debt Ratio | 35.36% |
| Total Debt | $1M |
| FCF | $12M |
| Cash | $96M |
| Current Ratio | 4.89x |
| Net Debt/EBITDA | -0.89x |
| Performance | |
| 1Y Return | 42.23% |
| 1M Return | 26.47% |
| From 52W High | -9.60% |
| 1Y MDD | -43.47% |
| Trading | |
| Volume | 1,720,449 shares |
| Trading Value | $22M |
| Per Share | |
| EPS | $1.50 |
| BPS | $2.80 |